However, conflicting data regarding poor prognostic value of Tregs raised a possibility of two distinct subtypes present in different tumor types: (I) suppressive Tregs, which are CD4 T cells that express CD45 receptor in both resting and activated states and (II) nonsuppressive Tregs, which are CD45 receptor negative CD4 T cells (7). This evidence concerns the gene CD4 and neoplasm.